# A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects With Active Axial Spondyloarthritis Including Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis

> clinical trial · VERIFIED · 2026-08-14

Status: ACTIVE_NOT_RECRUITING · Sponsor: UCB Biopharma SRL · Condition: Axial Spondyloarthritis

- Company: UCB Biopharma SRL
- Sector: therapeutics
- Primary source: https://clinicaltrials.gov/study/NCT04436640

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.